MedPath

Interest of Eye Movement Measurements in the Comprehension of Dry Eyes Symptoms

Completed
Conditions
Dry Eye Syndromes
Blinking
Interventions
Device: Infrared oculography
Registration Number
NCT02851654
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Brief Summary

Dry eye syndrome is a benign situation however its impact on patient's quality of live and on health system is not trivial. One problem is the lack of correlation between patient's symptoms and physical sign observed on slit lamp examination. Eye blinking is a parameter of increased interest in this pathology particularly its frequency. To date no treatment of dry eye syndrome has a proven impact on eye blinking frequency. However recording of blinks has mostly been performed on short duration (3 to 5 minutes) and the distribution of intervals between 2 blinks is not gaussian but exponential. In this study, it is proposed to use modern eye-movement recorder to measure the blink frequency on longer duration (12 minutes) while reading on a screen computer and during a face-to-face interview before and after treatment of meibomian gland dysfunction responsible of moderate to severe dry eye syndrome.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Moderate to severe dry eye syndrome (Ocular Surface Disease Index> 30) following a meibomian gland dysfunction
  • Not yet properly treated for a meibomian gland dysfunction
Exclusion Criteria
  • History of other ophthalmological or neurological disease
  • Pregnant or breastfeeding women
  • Patient under 18 years old
  • Patient under legal protection

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Dry eye syndromeInfrared oculographyMeibomian gland dysfunction responsible of moderate to severe dry eye syndrome
Primary Outcome Measures
NameTimeMethod
duration between 2 blinks2 months after treatment

Assessment by infrared oculography while the patient is reading on a computer screen and during a face-to-face interview

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fondation Ophtalmologique Adolphe de Rothschild (FOR)

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath